SARS-CoV-2 infection in cancer patients on active therapy after the booster dose of mRNA vaccines
mRNA 백신 추가 접종 후 활성 요법을 받는 암 환자의 SARS-CoV-2 감염
Article
Published on
Journal: European journal of cancer (Oxford, England : 1990 [Category] COVID19(2023년), MERS, SARS, 변종, 진단, 치료기술,
Journal: European journal of cancer (Oxford, England : 1990 [Category] COVID19(2023년), MERS, SARS, 변종, 진단, 치료기술,
[키워드] active treatment
anti-Spike IgG
booster
booster dose
Booster vaccine
cancer patient
Cancer patients
center
Cohort
COVID-19
Delta
dose
Follow-up
geometric mean
geometric mean titer
geometric mean titers
Health care
Health care worker
healthy subject
healthy subjects
indicate
investigated
Italy
lowest
malignancies
median value
microneutralization
Microneutralization assay
mRNA vaccine
mRNA vaccines
Nasopharyngeal swab
Neutralizing antibodies
neutralizing antibody
Occurrence
occurrence of COVID-19
omicron
Omicron variants
outbreak
Patient
positive
potential risk
proportion
protective role
required
SARS-CoV-2
SARS-COV-2 infection
SARS-CoV-2 variant
SARS-CoV-2 variants
serological
Siena
solid malignancies
solid malignancy
solid tumor
solid tumors
tested
the median
the SARS-CoV-2
therapy
Treatment
tumors
Type
university
Vaccine
variants
[DOI] 10.1016/j.ejca.2022.05.018 PMC 바로가기 [Article Type] Article
[DOI] 10.1016/j.ejca.2022.05.018 PMC 바로가기 [Article Type] Article